(Q38437441)

3 September 2017

title

Expression of bcl-2 family members in malignant pleural mesothelioma (English)

1 reference

3 September 2017

Sara L O'Kane

1

1 reference

3 September 2017

Rachelle J Pound

2

1 reference

3 September 2017

Anne Campbell

3

1 reference

3 September 2017

Nilanjan Chaudhuri

4

1 reference

3 September 2017

Michael J Lind

5

1 reference

3 September 2017

Lynn Cawkwell

6

1 reference

3 September 2017

publication date

1 January 2006

1 reference

3 September 2017

1 reference

3 September 2017

volume

45

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

449-453

1 reference

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

The role of Bcl-2 family members in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

BH3-Only proteins-essential initiators of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Mechanisms of apoptosis avoidance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Apoptosis pathways in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

p53 expression is common in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Metastasis in pleural mesothelioma. Immunohistochemical markers for disseminated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

Over-expression of tenascin-C in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500468927

10.1080/02841860500468927

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference